{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:15:05Z","timestamp":1791112505205,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.atherosclerosis.2006.12.035","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T09:27:24Z","timestamp":1172136444000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population"],"prefix":"10.1016","volume":"196","author":[{"given":"Yasuko","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kokubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitonobu","family":"Tomoike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2003.09.011","article-title":"Functional characterization of Narc 1, a novel proteinase related to proteinase K","volume":"420","author":"Naureckiene","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib3","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib4","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib5","doi-asserted-by":"crossref","first-page":"50630","DOI":"10.1074\/jbc.M410077200","article-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib6","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.0409736102","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib7","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0009-9163.2004.0238.x","article-title":"Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia","volume":"65","author":"Leren","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddl077","article-title":"Effect of mutations in the PCSK9 gene on the cell surface LDL receptors","volume":"15","author":"Cameron","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.0000204337.81286.1c","article-title":"Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy","volume":"26","author":"Berg","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10038-003-0114-3","article-title":"Genetic variants in PCSK9 affect the cholesterol level in Japanese","volume":"49","author":"Shioji","year":"2004","journal-title":"J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","article-title":"A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis","volume":"45","author":"Chen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.STR.28.3.518","article-title":"Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study","volume":"28","author":"Mannami","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib18","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1161\/01.STR.31.12.2958","article-title":"Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study","volume":"31","author":"Mannami","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib19","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/archinte.160.15.2297","article-title":"Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study","volume":"160","author":"Mannami","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1126\/science.1061815","article-title":"Molecular medicine. The cholesterol quartet","volume":"292","author":"Goldstein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(95)92627-5","article-title":"Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia","volume":"345","author":"Nohara","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjhyper.2003.12.020","article-title":"Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes","volume":"17","author":"Kamide","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1291\/hypres.27.333","article-title":"Six missense mutations of the epithelial sodium channel \u03b2-and \u03b3-subunits in Japanese hypertensives","volume":"27","author":"Kamide","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1291\/hypres.28.703","article-title":"A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: its implications for clinical phenotypes","volume":"28","author":"Kamide","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/01.hjh.0000174606.41651.ae","article-title":"Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population","volume":"23","author":"Yang","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1099870","article-title":"Multiple rare alleles contribute to low plasma levels of HDL cholesterol","volume":"305","author":"Cohen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.12.035_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI200420361","article-title":"Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population","volume":"114","author":"Frikke-Schmidt","year":"2004","journal-title":"J Clin Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:33:44Z","timestamp":1758155624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0021915007000512"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.12.035","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}